Zentalis shareholders elect three directors, approve auditor and say-on-pay at annual meeting

Zentalis Pharmaceuticals, Inc.

Scott Myers (43.0M for), Karan Takhar (30.7M for), and Luke Walker (36.6M for) elected as Class II directors.
Ratification of Ernst & Young as auditor approved with 58.1M votes for (over 99.9% of votes cast).
Advisory say-on-pay passed with 29.5M for vs 17.4M against (~63% of votes cast excluding broker non-votes).
Total 58.2M shares voted (80.9% of outstanding common stock as of April 21, 2025 record date).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.